OLMA

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Olema Pharmaceuticals Inc

NASDAQ | OLMA

28.32

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$2.25B

Market Cap

-

P/E Ratio

-1.76

EPS

$29.51

52 Week High

$2.86

52 Week Low

HEALTHCARE

Sector

OLMA Chart

Recent Chart
Price Action

OLMA Technicals

Tags:

OLMA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$393K
Total Revenue $0
Cost Of Revenue $393K
Costof Goods And Services Sold $393K
Operating Income -$142M
Selling General And Administrative $18M
Research And Development $125M
Operating Expenses $142M
Investment Income Net -
Net Interest Income $13M
Interest Income $13M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $393K
Income Before Tax -$129M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$129M
Comprehensive Income Net Of Tax -
Ebit -$142M
Ebitda -$142M
Net Income -$129M

Revenue & Profitability

Earnings Performance

OLMA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $451M
Total Current Assets $438M
Cash And Cash Equivalents At Carrying Value $139M
Cash And Short Term Investments $139M
Inventory -$4M
Current Net Receivables $2.1M
Total Non Current Assets $13M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $683K
Intangible Assets Excluding Goodwill $683K
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $295M
Other Current Assets $2.3M
Other Non Current Assets -
Total Liabilities $42M
Total Current Liabilities $42M
Current Accounts Payable $4.5M
Deferred Revenue -
Current Debt -
Short Term Debt $1.2M
Total Non Current Liabilities $257K
Capital Lease Obligations $1.4M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.4M
Other Current Liabilities $36M
Other Non Current Liabilities -
Total Shareholder Equity $409M
Treasury Stock -
Retained Earnings -$435M
Common Stock $6K
Common Stock Shares Outstanding $59M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$104M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $393K
Capital Expenditures $159K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$94M
Cashflow From Financing $269M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$129M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$393K
Total Revenue $0
Cost Of Revenue $393K
Costof Goods And Services Sold $393K
Operating Income -$142M
Selling General And Administrative $18M
Research And Development $125M
Operating Expenses $142M
Investment Income Net -
Net Interest Income $13M
Interest Income $13M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $393K
Income Before Tax -$129M
Income Tax Expense -$1
Interest And Debt Expense -
Net Income From Continuing Operations -$129M
Comprehensive Income Net Of Tax -
Ebit -$142M
Ebitda -$142M
Net Income -$129M

OLMA News

OLMA Profile

Olema Pharmaceuticals Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Olema Pharmaceuticals, Inc. is an innovative clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing targeted therapies for women's cancers. With a strong commitment to addressing significant unmet medical needs within this historically underrepresented patient population, Olema is advancing a promising pipeline of novel compounds designed to enhance patient outcomes. Positioned strategically within the oncology landscape, the company is currently navigating pivotal clinical trials, leveraging its scientific acumen to potentially reshape standard care practices in women's health. As it evolves, Olema remains dedicated to providing transformative treatment solutions that hold the potential to redefine the therapeutic landscape in this vital area of medicine.

LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
INHD
-0.99%
$0.22
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.68%
$13.28
BURU
+10.43%
$0.24
WLGS
-5.57%
$0.04
GPUS
-9.24%
$0.30
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
ACHR
+4.40%
$7.82
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.76%
$8.37
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.30%
$2.44
VHAI
-25.00%
$0.00
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+2.05%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.29%
$16.81
LPTX
+368.57%
$2.05
KTTA
+38.67%
$1.47
NVDA
-1.80%
$177.00
HBI
-1.82%
$6.47
VINE
+21.21%
$0.48
AMZE
+19.82%
$0.47
TLRY
-21.06%
$0.81
INTC
+10.18%
$40.56
BITF
+12.25%
$3.48
IPG
-1.95%
$24.57
TWOH
-15.38%
$0.00
YGMZ
-9.59%
$0.11
BYND
-3.74%
$0.98
AXDX
-61.36%
$0.03
BMNR
+4.34%
$33.12
CLSK
+12.26%
$15.10
ADAP
-15.14%
$0.05
RUBI
-26.17%
$0.15
ASST
-0.88%
$1.12
PLUG
+1.51%
$2.01
SOND
-23.45%
$0.12
SNAP
+0.72%
$7.66
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
BIYA
+17.05%
$0.29
AAL
+0.86%
$14.05
INHD
-0.99%
$0.22
TSLA
+0.84%
$430.17
SRM
+53.27%
$10.30
CIFR
+6.26%
$20.35
ONMD
+30.28%
$1.85
BMNU
+8.77%
$8.18
ONDS
-4.12%
$7.90
MARA
+6.30%
$11.81
WULF
+4.51%
$15.51
NIO
+0.82%
$5.50
F
+0.68%
$13.28
BURU
+10.43%
$0.24
WLGS
-5.57%
$0.04
GPUS
-9.24%
$0.30
MTSR
-0.35%
$70.50
SOFI
+4.31%
$29.72
VALE
+0.79%
$12.61
GOOGL
+0.07%
$320.18
BTBT
+2.58%
$2.38
DEFT
+9.35%
$1.52
ADTX
+21.01%
$3.80
BTG
+3.80%
$4.64
ACHR
+4.40%
$7.82
GRAB
+2.44%
$5.45
AFMD
-34.94%
$0.18
DVLT
-4.69%
$2.03
PFE
+0.11%
$25.74
CAN
+0.75%
$0.92
CRCL
+10.03%
$79.93
SMX
+250.80%
$61.04
KWM
+13.63%
$0.75
DNN
-0.19%
$2.55
IBRX
+10.79%
$2.36
VEEE
+45.50%
$2.59
RIOT
+7.82%
$16.13
AMZN
+1.77%
$233.22
AAPL
+0.46%
$278.85
AIIO
-9.09%
$0.70
WBD
+0.50%
$24.00
AG
+12.65%
$15.22
APLD
+8.66%
$27.10
NGD
+6.76%
$8.37
GOOG
-0.05%
$320.12
IREN
-1.32%
$47.81
RIG
+2.55%
$4.41
GRYP
-10.38%
$1.38
BAC
+1.28%
$53.67
MODV
-25.22%
$0.43
AMD
+1.53%
$217.53
RIVN
+4.20%
$16.86
SMR
+5.04%
$20.00
WMT
+1.96%
$109.10
TMC
+19.38%
$6.96
PLTR
+1.61%
$168.45
CDE
+6.76%
$17.28
ITUB
+1.82%
$7.80
AGNC
-0.66%
$10.49
CRCA
+19.56%
$4.40
T
+0.77%
$26.02
AMC
+6.30%
$2.44
VHAI
-25.00%
$0.00
NVO
+1.21%
$49.30
CRCG
+20.00%
$2.82
META
-0.41%
$633.61
MSTR
+0.87%
$177.18
NFLX
+1.35%
$107.58
SAND
-6.04%
$12.12
BBD
+0.54%
$3.70
BTE
+2.05%
$3.22
MSFT
+1.34%
$492.01
HBAN
+0.18%
$16.30
HL
+5.29%
$16.81
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.